SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Sight Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$8.26−0.02 (-0.24%)
Close on Oct 19, 2026
- Market cap
- $450.22M
- P/E (TTM)
- –
- Dividend yield
- –
Sight Sciences, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 88.0%
- Operating margin
- -33.4%
- Net margin
- -35.7%
- Return on equity, FY2025
- -50.7%
Financial strength
- Current ratio
- 4.95
- Debt to equity
- 0.96
- Debt to assets
- 48.5%
- Cash to current liabilities
- 389.1%
Valuation
- P/E ratio
- –
- Price to sales
- 5.40
- Price to book
- 8.51
- Dividend yield
- –